Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114814503 | 11481450 | 3 | F | 201109 | 20160912 | 20150903 | 20160922 | EXP | US-ELI_LILLY_AND_COMPANY-US201203005165 | ELI LILLY AND CO | 56.77 | YR | F | Y | 0.00000 | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114814503 | 11481450 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN | Y | 21427 | CAPSULE | ||||||||
| 114814503 | 11481450 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 30 MG, QD | Y | 21427 | 30 | MG | CAPSULE | QD | ||||||
| 114814503 | 11481450 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, UNKNOWN | Y | 21427 | 60 | MG | CAPSULE | |||||||
| 114814503 | 11481450 | 4 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 90 MG, UNKNOWN | Y | 21427 | 90 | MG | CAPSULE | |||||||
| 114814503 | 11481450 | 5 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, UNKNOWN | Y | A860193A | 21427 | 60 | MG | CAPSULE | ||||||
| 114814503 | 11481450 | 6 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 30 MG, QD | Y | A922541A | 21427 | 30 | MG | CAPSULE | QD | |||||
| 114814503 | 11481450 | 7 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 114814503 | 11481450 | 8 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | U | 0 | |||||||||||
| 114814503 | 11481450 | 9 | C | ATIVAN | LORAZEPAM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114814503 | 11481450 | 1 | Depression |
| 114814503 | 11481450 | 2 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114814503 | 11481450 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114814503 | 11481450 | Depression | |
| 114814503 | 11481450 | Dyspepsia | |
| 114814503 | 11481450 | Fall | |
| 114814503 | 11481450 | Gastrooesophageal reflux disease | |
| 114814503 | 11481450 | Hypertension | |
| 114814503 | 11481450 | Intentional product misuse | |
| 114814503 | 11481450 | Mood swings | |
| 114814503 | 11481450 | Pain | |
| 114814503 | 11481450 | Paraesthesia | |
| 114814503 | 11481450 | Rash pruritic | |
| 114814503 | 11481450 | Suicidal ideation | |
| 114814503 | 11481450 | Tinnitus | |
| 114814503 | 11481450 | Weight decreased | |
| 114814503 | 11481450 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114814503 | 11481450 | 2 | 20051031 | 0 |